Showing results (361-370 of 481) with videos related to
Sort By:
Pageof 49
Blood|September 8, 2012
Targeting JAK1/2 and mTOR in murine xenograft models of Ph-like acute lymphoblastic leukemiaShannon L Maude, Sarah K Tasian, Tiffaney Vincent, et al.Blood Advances|May 5, 2026
Toxicity from asparaginase during acute lymphoblastic leukemia induction: A report from the Children's Oncology GroupEtan Orgel, Luke D Maese, Meenakshi Devidas, et al.Blood|November 22, 2015
Genetic risk factors for the development of osteonecrosis in children under age 10 treated for acute lymphoblastic leukemiaSeth E Karol, Leonard A Mattano, Wenjian Yang, et al.Proceedings of the National Academy of Sciences of the United States of America|January 25, 2013
Mutation of the ATP-gated P2X(2) receptor leads to progressive hearing loss and increased susceptibility to noiseDenise Yan, Yan Zhu, Tom Walsh, et al.Cancer|February 24, 2022
Sex-based disparities in outcome in pediatric acute lymphoblastic leukemia: a Children's Oncology Group reportSumit Gupta, David T Teachey, Zhiguo Chen, et al.Blood|May 20, 2015
Genome-wide analysis links NFATC2 with asparaginase hypersensitivityChristian A Fernandez, Colton Smith, Wenjian Yang, et al.Cancer Research|December 18, 2004
Activating mutations of the noonan syndrome-associated SHP2/PTPN11 gene in human solid tumors and adult acute myelogenous leukemiaMohamed Bentires-Alj, J Guillermo Paez, Frank S David, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 29, 2014
Pharmacokinetic and pharmacodynamic properties of calaspargase pegol Escherichia coli L-asparaginase in the treatment of patients with acute lymphoblastic leukemia: results from Children's Oncology Group Study AALL07P4Anne L Angiolillo, Reuven J Schore, Meenakshi Devidas, et al.Plos One|November 14, 2019
Fanconi-BRCA pathway mutations in childhood T-cell acute lymphoblastic leukemiaGayle P Pouliot, James Degar, Laura Hinze, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 5, 2020
Impact of Intrathecal Triple Therapy Versus Intrathecal Methotrexate on Disease-Free Survival for High-Risk B-Lymphoblastic Leukemia: Children's Oncology Group Study AALL1131Wanda L Salzer, Michael J Burke, Meenakshi Devidas, et al.Pageof 49